+381 11 38 17 057
info@blueseacap.com

News

Blue Sea Capital participates in the acquisition of three leading food and beverages companies in Serbia

Blue Sea Capital is pleased to announce its participation in the investment consortium led by Mid Europa Partners, which has now completed the acquisition of three leading food and beverages companies in Serbia: Imlek, Bambi and Knjaz Milos. Imlek is the biggest independent dairy producer in Central Eastern Europe with an impressive portfolio of dairy products. Bambi is a leading confectionary producer with its trademark „Plazma“ biscuit commanding exceptional brand loyalty. Knjaz Milos is a leading producer of and a leading brand in mineral water in Serbia. (more…)

Blue Sea Capital completes investment in ophthalmology clinic Milos Klinika

Blue Sea Capital is pleased to announce that it completed its sixth investment, the acquisition of ophthalmology clinic Milos Klinika. Milos Klinika is one of the leading regional ophthalmology clinics, primarily involved in cataract and cataract related surgeries, vitrectomy and LASIK surgeries. In 2013 it performed almost 4,000 surgeries and 9,000 examinations. Sasa Galic, Managing Partner of Blue Sea Capital, said: “We are pleased that we have completed this investment, an investment which underlines our belief in the strong growth prospects of both the ophthalmology medical area and the overall private healthcare sector in Serbia.” (more…)

Blue Sea Capital invests in ophthalmology clinic Milos Klinika

Blue Sea Capital is pleased to announce the signing of an agreement to acquire Milos Klinika, a leading ophthalmology clinic based in Belgrade, Serbia. Milos Klinika (“the Clinic“) prides itself on its exceptional medical team led by Prof. Dr Zoran Kuljača, a distinguished and recognised ophthalmology expert. The Clinic delivers the highest standard of care to its patients across the region. (more…)

MediGroup acquires hospital building

Blue Sea Capital announces MediGroup’s acquisition of the hospital building situated at Milutina Milankovica 3, Belgrade. MediGroup, which currently consists of leading health centres Dr Ristic and Jedro and gynaecological hospital (with maternity ward) Jevremova, is a leading private provider of healthcare services in Serbia. (more…)

The opening of Serbia’s largest private general hospital facility

Blue Sea Capital is pleased to announce that its Serbian healthcare platform MediGroup has opened MediGroup general hospital. The hospital is equipped to the latest healthcare technology standards, and offers superior in-patient accommodation and healthcare treatment to its rapidly growing number of patients from Belgrade, as well as from across the country. (more…)

MediGroup completes investment in Health Centre Jedro

Blue Sea Capital is pleased to announce that its Serbian health care platform MediGroup today completed its acquisition of Dom Zdravlja Jedro from Delta Generali Insurance, adding the third largest outpatient provider in Serbia to MediGroup. In addition, MediGroup signed an agreement with Delta Generali, expanding cooperation with the leader in private health insurance in Serbia. (more…)

MediGroup invests in Health Centre Jedro

Blue Sea Capital is pleased to announce that its Serbian health care platform MediGroup today signed an agreement to acquire Dom Zdravlja Jedro from Delta Generali Insurance, adding one of the largest outpatient providers in Serbia to MediGroup and expanding cooperation with Delta Generali, the leader in private health insurance in Serbia. (more…)

The launch of Serbia’s first private health care platform

The Serbian health care market has traditionally been characterised by a large number of independent medical providers, not necessarily cooperating with each other or sharing expertise and resources. This pattern, with the recent creation of MediGroup, is now subject to an exciting change. (more…)

Blue Sea invests in hospital Jevremova

Blue Sea Capital is pleased to announce its investment into Jevremova, the Serbia’s leading gynaecological and IVF clinic. (more…)

EBRD supports Piramida

The EBRD is investing €3.6 million to strengthen the Croatian pharmaceutical packaging producer Piramida d.o.o. and in plans to expand the company’s production. While €2.7 million will be used for balance sheet restructuring, the remaining €0.9 million will finance additional production facilities. (more…)